|
1
|
Davis ME: Epidemiology and overview of
gliomas. Semin Oncol Nurs. 34:420–429. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ostrom QT, Gittleman H, Stetson L, Virk SM
and Barnholtz-Sloan JS: Epidemiology of gliomas. Cancer Treat Res.
163:1–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ostrom QT, Gittleman H, Liao P, Rouse C,
Chen Y, Dowling J, Wolinsky Y, Kruchko C and Barnholtz-Sloan J:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the United States in 2007–2011. Neuro Oncol. 16
(Suppl 4):iv1–iv63. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rasmussen BK, Hansen S, Laursen RJ,
Kosteljanetz M, Schultz H, Nørgård BM, Guldberg R and Gradel KO:
Epidemiology of glioma: Clinical characteristics, symptoms, and
predictors of glioma patients grade I–IV in the the Danish
neuro-oncology registry. J Neurooncol. 135:571–579. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kawai T and Akira S: Toll-like receptors
and their crosstalk with other innate receptors in infection and
immunity. Immunity. 34:637–650. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kumar H, Kawai T and Akira S: Toll-like
receptors and innate immunity. Biochem Biophys Res Commun.
388:621–625. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hua Z and Hou B: TLR signaling in B-cell
development and activation. Cell Mol Immunol. 10:103–106. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kawai T and Akira S: TLR signaling. Semin
Immunol. 19:24–32. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Seydoux E, Liang H, Dubois Cauwelaert N,
Archer M, Rintala ND, Kramer R, Carter D, Fox CB and Orr MT:
Effective combination adjuvants engage both TLR and inflammasome
pathways to promote potent adaptive immune responses. J Immunol.
201:98–112. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tian S, Wang M, Liu C, Zhao H and Zhao B:
Mulberry leaf reduces inflammation and insulin resistance in type 2
diabetic mice by TLRs and insulin signalling pathway. BMC
Complement Altern Med. 19:3262019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dickinson SE and Wondrak GT: TLR4-directed
molecular strategies targeting skin photodamage and carcinogenesis.
Curr Med Chem. 25:5487–5502. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang YH, Cao YW, Yang XC, Niu HT, Sun LJ,
Wang XS and Liu J: Effect of TLR4 and B7-H1 on immune escape of
urothelial bladder cancer and its clinical significance. Asian Pac
J Cancer Prev. 15:1321–1326. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Monlish DA, Bhatt ST and Schuettpelz LG:
The role of toll-like receptors in hematopoietic malignancies.
Front Immunol. 7:3902016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dajon M, Iribarren K and Cremer I:
Toll-like receptor stimulation in cancer: A pro- and anti-tumor
double-edged sword. Immunobiology. 222:89–100. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Makkar S, Riehl TE, Chen B, Yan Y,
Alvarado DM, Ciorba MA and Stenson WF: Hyaluronic acid binding to
TLR4 promotes proliferation and blocks apoptosis in colon cancer.
Mol Cancer Ther. 18:2446–2456. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun NK, Huang SL, Chang TC and Chao CC:
TLR4 and NFκB signaling is critical for taxol resistance in ovarian
carcinoma cells. J Cell Physiol. 233:2489–2501. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shetab Boushehri MA and Lamprecht A:
TLR4-based immunotherapeutics in cancer: A review of the
achievements and shortcomings. Mol Pharm. 15:4777–4800. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dapito DH, Mencin A, Gwak GY, Pradere JP,
Jang MK, Mederacke I, Caviglia JM, Khiabanian H, Adeyemi A,
Bataller R, et al: Promotion of hepatocellular carcinoma by the
intestinal microbiota and TLR4. Cancer Cell. 21:504–516. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Allen M, Bjerke M, Edlund H, Nelander S
and Westermark B: Origin of the U87MG glioma cell line: Good news
and bad news. Sci Transl Med. 8:354re32016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou T, Li Y, Yang L, Liu L, Ju Y and Li
C: Silencing of ANXA3 expression by RNA interference inhibits the
proliferation and invasion of breast cancer cells. Oncol Rep.
37:388–398. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ostrom QT, Bauchet L, Davis FG, Deltour I,
Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh
KM, et al: The epidemiology of glioma in adults: A ‘state of the
science’ review. Neuro Oncol. 16:896–913. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lim M, Xia Y, Bettegowda C and Weller M:
Current state of immunotherapy for glioblastoma. Nat Rev Clin
Oncol. 15:422–442. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Satoh T and Akira S: Toll-like receptor
signaling and its inducible proteins. Microbiol Spectr.
4:2016.PubMed/NCBI
|
|
25
|
Steinhagen F, Kinjo T, Bode C and Klinman
DM: TLR-based immune adjuvants. Vaccine. 29:3341–3355. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kumar V: Toll-like receptors in the
pathogenesis of neuroinflammation. J Neuroimmunol. 332:16–30. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Medzhitov R, Preston-Hurlburt P and
Janeway CA Jr: A human homologue of the Drosophila Toll
protein signals activation of adaptive immunity. Nature.
388:394–397. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vijay K: Toll-like receptors in immunity
and inflammatory diseases: Past, present, and future. Int
Immunopharmacol. 59:391–412. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mikulic J, Longet S, Favre L, Benyacoub J
and Corthesy B: Secretory IgA in complex with Lactobacillus
rhamnosus potentiates mucosal dendritic cell-mediated Treg cell
differentiation via TLR regulatory proteins, RALDH2 and secretion
of IL-10 and TGF-β. Cell Mol Immunol. 14:546–556. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang AT, Choi JP, Kotzin JJ, Yang Y, Hong
CC, Hobson N, Girard R, Zeineddine HA, Lightle R, Moore T, et al:
Endothelial TLR4 and the microbiome drive cerebral cavernous
malformations. Nature. 545:305–310. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yin Q, Jiang D, Li L, Yang Y, Wu P, Luo Y,
Yang R and Li D: LPS promotes vascular smooth muscle cells
proliferation through the TLR4/Rac1/Akt signalling pathway. Cell
Physiol Biochem. 44:2189–2200. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fu HY, Li C, Yang W, Gai XD, Jia T, Lei YM
and Li Y: FOXP3 and TLR4 protein expression are correlated in
non-small cell lung cancer: Implications for tumor progression and
escape. Acta Histochem. 115:151–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Grimmig T, Matthes N, Hoeland K, Tripathi
S, Chandraker A, Grimm M, Moench R, Moll EM, Friess H, Tsaur I, et
al: TLR7 and TLR8 expression increases tumor cell proliferation and
promotes chemoresistance in human pancreatic cancer. Int J Oncol.
47:857–866. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xiao T, Wu S, Yan C, Zhao C, Jin H, Yan N,
Xu J, Wu Y, Li C, Shao Q and Xia S: Butyrate upregulates the TLR4
expression and the phosphorylation of MAPKs and NK-κB in colon
cancer cell in vitro. Oncol Lett. 16:4439–4447.
2018.PubMed/NCBI
|
|
35
|
Li C, Li H, Jiang K, Li J and Gai X: TLR4
signaling pathway in mouse Lewis lung cancer cells promotes the
expression of TGF-β1 and IL-10 and tumor cells migration. Biomed
Mater Eng. 24:869–875. 2014.PubMed/NCBI
|
|
36
|
Ren WH, Zhang LM, Liu HQ, Gao L, Chen C,
Qiang C, Wang XL, Liu CY, Li SM, Huang C, et al: Protein
overexpression of CIRP and TLR4 in oral squamous cell carcinoma: An
immunohistochemical and clinical correlation analysis. Med Oncol.
31:1202014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pandey N, Chauhan A and Jain N: TLR4
polymorphisms and expression in solid cancers. Mol Diagn Ther.
22:683–702. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen CL, Tsukamoto H, Liu JC, Kashiwabara
C, Feldman D, Sher L, Dooley S, French SW, Mishra L, Petrovic L, et
al: Reciprocal regulation by TLR4 and TGF-β in tumor-initiating
stem-like cells. J Clin Invest. 123:2832–2849. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yao RR, Li JH, Zhang R, Chen RX and Wang
YH: M2-polarized tumor-associated macrophages facilitated migration
and epithelial-mesenchymal transition of HCC cells via the
TLR4/STAT3 signaling pathway. World J Surg Oncol. 16:92018.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Szajnik M, Szczepanski MJ, Czystowska M,
Elishaev E, Mandapathil M, Nowak-Markwitz E, Spaczynski M and
Whiteside TL: TLR4 signaling induced by lipopolysaccharide or
paclitaxel regulates tumor survival and chemoresistance in ovarian
cancer. Oncogene. 28:4353–4363. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang H and Zhang S: The expression of
Foxp3 and TLR4 in cervical cancer: Association with immune escape
and clinical pathology. Arch Gynecol Obstet. 295:705–712. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhan Z, Xie X, Cao H, Zhou X, Zhang XD,
Fan H and Liu Z: Autophagy facilitates TLR4- and TLR3-triggered
migration and invasion of lung cancer cells through the promotion
of TRAF6 ubiquitination. Autophagy. 10:257–268. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li J, Yin J, Shen W, Gao R, Liu Y, Chen Y,
Li X, Liu C, Xiang R and Luo N: TLR4 promotes breast cancer
metastasis via Akt/GSK3β/β-catenin pathway upon LPS stimulation.
Anat Rec (Hoboken). 300:1219–1229. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kim KH, Jo MS, Suh DS, Yoon MS, Shin DH,
Lee JH and Choi KU: Expression and significance of the TLR4/MyD88
signaling pathway in ovarian epithelial cancers. World J Surg
Oncol. 10:1932012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhou Q, Wang C, Wang X, Wu X, Zhu Z, Liu B
and Su L: Association between TLR4 (+896A/G and +1196C/T)
polymorphisms and gastric cancer risk: An updated meta-analysis.
PLoS One. 9:e1096052014. View Article : Google Scholar : PubMed/NCBI
|
